In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share.

The U.S. IPO activity looks sluggish amid the holiday-shortened week. Nevertheless, the week prior saw Texas-based cybersecurity firm SailPoint price its upsized IPO of 60M shares at a public offering ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be ...

Anbio Biotechnology NNNN IPO will take place February, 19 on the NASDAQ exchange under the ticker NNNN. The company is offering shares at an expected price between $5.00 and $6.00 per share with an ...

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

Focus to be on forging strategic partnerships in biotechnology manufacturing, clinical research, AI-driven healthcare, and advanced vaccine development ...

UK-based biotechnology firm Stablepharma Ltd has been awarded €2.5 million through the prestigious European Innovation ...

Asset Management One Co. Ltd. raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during ...

USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the ...

India is no longer just a follower but is now setting global benchmarks, offering leadership and pioneering innovations ...